Overexpression of CD44 is associated with a poor prognosis in grade II/III gliomas
ConclusionsThe present study suggests that overexpression ofCD44 is associated with a poor prognosis for grade II/III glioma patients. Moreover, our findings suggest thatCD44 could serve as a prognostic biomarker in grade II/III glioma patients.
Source: Journal of Neuro-Oncology - Category: Cancer & Oncology Source Type: research
More News: Brain | Brain Cancers | Brain Tumor | Cancer | Cancer & Oncology | China Health | Databases & Libraries | Glioma | Neurology | Stem Cell Therapy | Stem Cells | Study